CRISPR gene editing: Materials
Materials it needs
The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is
Uses- Enz Industrial enzymes criticality low The Cas protein is the cutting enzyme of the system [1].
- Pep Peptides and oligonucleotides criticality low The guide RNA is a short nucleic acid made to order for each target.
- Rgt Reagents and high-purity lab chemicals criticality low Research and production use high-purity laboratory chemicals and growth media.
as of 2026-11-11. No amounts are given: the inputs are small amounts of specialised chemicals, and the dual-use rule keeps production detail out. Criticality is the writer's judgement.
Critical materials
The materials whose supply could hold it back
- No raw material is likely to hold gene editing back: enzymes and short RNAs are made in small amounts.
- The constraints are policy ones: medicines need approval by regulators such as the MHRA and FDA [3, 4], and WHO's 2021 recommendations call for registries of human genome editing research and a way to report concerns [5].
- Editing embryos so that changes pass to children carries risks that WHO singles out [5].
as of 2026-11-11
Sources
- A Tool for Genome Editing: Scientific Background on the Nobel Prize in Chemistry 2020 Royal Swedish Academy of Sciences, 2020
- FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease US Food and Drug Administration, 2023
- MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia Medicines and Healthcare products Regulatory Agency (GOV.UK), 2023
- WHO issues new recommendations on human genome editing for the advancement of public health World Health Organization, 2021